RESUMO
INTRODUCTION: The achievement of the goal of the World Health Organization to eliminate viral hepatitis B by 2030 seems to be problematic partly due to the presence of escape mutants of its etiological agent, hepatitis B virus (HBV) (<i>Hepadnaviridae: Orthohepadnavirus: Hepatitis B virus</i>), that are spreading mainly in the risk groups. Specific routine diagnostic assays aimed at identification of HBV escape mutants do not exist.The study aimed the evaluation of the serological fingerprinting method adapted for routine detection of escape mutations in 143 and 145 aa positions of HBV surface antigen (HBsAg). MATERIAL AND METHODS: HBV DNA from 56 samples of HBsAg-positive blood sera obtained from donors, chronic HBsAg carriers and oncohematology patients has been sequenced. After the identification of mutations in HBsAg, the samples were tested in the enzyme-linked immunosorbent assay (ELISA) kit «Hepastrip-mutant-3K¼. RESULTS AND DISCUSSION: Escape mutations were detected mainly in patients with hematologic malignancies. Substitutions in 143 and 145 aa were found in 10.81% and in 8.11% of such patients, respectively. The G145R mutation was recognized using ELISA kit in almost all cases. The kit specifically recognized the S143L substitution in contrast to the S143T variant. The presence of neighbor mutation D144E can be assumed due to it special serological fingerprint. CONCLUSION: ELISA-based detection of escape mutations S143L, D144E and G145R can be used for routine diagnostics, especially in the risk groups. The diagnostic parameters of the kit can be refined in additional studies. This immunoassay and methodology are applicable for the development and quality control of vaccines against escape mutants.
Assuntos
Hepadnaviridae , Hepatite B , DNA Viral/genética , Ensaio de Imunoadsorção Enzimática , Hepadnaviridae/genética , Hepatite B/diagnóstico , Hepatite B/genética , Antígenos de Superfície da Hepatite B/genética , Vírus da Hepatite B/genética , Humanos , Mutação , Orthohepadnavirus/genéticaRESUMO
INTRODUCTION: Oral cavity squamous cell carcinoma (OC-SCC) is the most common and aggressive malignancy of the oral cavity. Recent studies have revealed infections with human papilloma virus (HPV) as an additional risk factor for oral squamous cell carcinoma development, while distinguished role of Epstein-Barr virus (EBV) remains still uncertain. However, the evidence for association between virus infection and risk of oral squamous cell carcinoma is controversially and varies significantly by geographic regions and race. PURPOSE: The aim of the present study was to elucidate the prevalence of HPV and EBV in OC-SCC samples of Russian patients from Moscow region. MATERIAL AND METHODS: We investigated fresh-frozen tumor tissue fragments obtained from 11 patients with OC-SCC. DNA was extracted and the viral genome was examined by quantitative PCR assays with highrisk type-specific HPV and EBV specific markers followed by sequencing-based analysis. RESULTS: No HPV infection in analyzed OC-SCC samples was observed, while EBV was identified in 70.0% (7/10) of patients. Further based on Q-PCR amplification of the EBV targets including BamHI-W, EBNA1 and C-terminal fragment of LMP1 gene, EBV infection and measurement of virus load in the tumor samples was assessed. Sequencing LMP1-positive products revealed that the most samples (5/6) contained variants LMP1 with Cao deletion characterized by an increased transforming potential. CONCLUSION: These data suggest that prevalence of EBV infections is common and may influence cancer development, although detected LMP1 variants of EBV are not necessarily associated with the pathogenesis of OC-SCC. Further studies are necessary to determine the potential role of EBV and its possible importance as an infection factor in OC-SCC.
Assuntos
Carcinoma de Células Escamosas , Infecções por Vírus Epstein-Barr , Genoma Viral , Herpesvirus Humano 4/genética , Neoplasias Bucais , Proteínas Oncogênicas Virais/genética , Adulto , Idoso , Carcinoma de Células Escamosas/genética , Carcinoma de Células Escamosas/patologia , Carcinoma de Células Escamosas/virologia , Infecções por Vírus Epstein-Barr/genética , Infecções por Vírus Epstein-Barr/patologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Moscou , Neoplasias Bucais/genética , Neoplasias Bucais/patologia , Neoplasias Bucais/virologiaRESUMO
Pretreatment with the active substance of antiviral preparation Kagocel, inductor of type I endogenous IFN, in a daily therapeutic dose (30 µg/mouse) 3 h prior to administration of S. typhimurium antigens to CBA mice reduced the number of bone marrow multipotent stromal cell (significantly increased by 3.2 times on the next day after antigen injection) to the initial level. Thus, activation of the stromal tissue induced by administration of the bacterial antigen was blocked. In addition, preliminary administration of Kagocel modulated the cytokine profile of the blood serum affected by S. typhimurium antigens: reduced 1.6-fold elevated concentration a proinflammatory cytokine TNFα to the control level (in 4 h after antigen injection) and maintained this level in 20 h after antigen administration. Kagocel also maintained the concentration of anti-inflammatory cytokine IL-10 at the level surpassing the normal by 1.6 times and high concentrations of Th1 cytokines (IL-2, IFNγ, and IL-12). These results suggest that Kagocel can reduce the immune response to bacterial antigens (similar to type I IFN [7]), which can contribute to its therapeutic and preventive effects in addition to its well documented antiviral activity and then this preparation can be used for the therapy of diseases accompanied by excessive or chronic inflammation.
Assuntos
Antígenos de Bactérias/administração & dosagem , Células da Medula Óssea/efeitos dos fármacos , Gossipol/análogos & derivados , Indutores de Interferon/farmacologia , Interleucina-10/biossíntese , Células-Tronco Multipotentes/efeitos dos fármacos , Animais , Antígenos de Bactérias/isolamento & purificação , Células da Medula Óssea/imunologia , Contagem de Células , Esquema de Medicação , Gossipol/farmacologia , Interferon gama/agonistas , Interferon gama/biossíntese , Interleucina-10/agonistas , Interleucina-12/agonistas , Interleucina-12/biossíntese , Interleucina-2/agonistas , Interleucina-2/biossíntese , Camundongos , Camundongos Endogâmicos CBA , Células-Tronco Multipotentes/imunologia , Salmonella typhimurium/química , Salmonella typhimurium/patogenicidade , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Fator de Necrose Tumoral alfa/biossínteseRESUMO
Current treatment options for patients with chronic hepatitis B virus (HBV) infection are not curative as they are not effective in eliminating covalently closed circular DNA (cccDNA). cccDNA is a stable template for HBV transcription in the nucleus of hepatocytes and is thought to be one of the main factors responsible for HBV persistence. Recently, activation of the lymphotoxin beta receptor (LTßR) has been shown to trigger degradation of cccDNA through induction of cytidine deaminases of the APOBEC3 family in HBV cell culture model systems. To assess the presence and relevance of such mechanisms in the liver of chronically HBV-infected patients, we compared intrahepatic cccDNA levels with the expression levels of lymphotoxins and some of their target genes (eg APOBEC deaminases) in liver biopsy tissue. Our results confirm elevated gene expression levels of components of the lymphotoxin pathway including lymphotoxin alpha (LTα), lymphotoxin beta (LTß), APOBEC3B (A3B) and APOBEC3G (A3G) in the chronically HBV-infected liver compared to uninfected liver. Furthermore, expression levels of the genes of the APOBEC deaminase family were correlated with those of LTα and LTß gene expression, consistent with lymphotoxin-mediated upregulation of APOBEC gene expression. However, intrahepatic cccDNA and HBV replication levels were not correlated with LTα, LTß and APOBEC gene expression. In conclusion, these results suggest that although the lymphotoxin pathway is activated in the chronically HBV-infected liver, it has no major impact on HBV cccDNA metabolism in chronic HBV infection.
Assuntos
DNA Circular/análise , Vírus da Hepatite B/crescimento & desenvolvimento , Hepatite B Crônica/patologia , Hepatite B Crônica/virologia , Homeostase , Receptor beta de Linfotoxina/metabolismo , Linfotoxina-alfa/metabolismo , Citidina Desaminase/metabolismo , Perfilação da Expressão Gênica , Vírus da Hepatite B/imunologia , Hepatite B Crônica/imunologia , HumanosRESUMO
The efficiency of cloning of bone marrow multipotent stromal cells (ECF-MSC) from CBA mice and the MSC counts in the femoral bone increased 24 h after a single in vivo (but not in vitro) injection of kagocel (active substance of antiviral drug Kagocel (®) ) 1.4 times (in response to 50-80 µg) and 4.6 times (in response to 250 µg). The maximum increase of ECF-MSC in response to 50 µg per mouse was detected just 1 h after Kagocel injection to intact mice and to mice previously receiving the drug for 3 days (2 and 1.7 times, respectively). The increase of ECF-MSC was 3-fold less intense in response to oral Kagocel in a dose of 250 µg/mouse vs. intraperitoneal Kagocel, ECF-MSC corresponding to its level in response to oral Poly (I:C). In vivo Kagocel led to emergence of proinflammatory cytokine IFN-γ, IL-1ß, and IL-8 mRNA in primary cultures of bone marrow stromal cells. Serum concentrations of IL-2, IL-5, IL-10, GM-CSF, IFN-γ, TNF-α, IL-4, and IL-12 increased 1.5 and 2 times just 1 h after Kagocel injection in doses of 30-50 and 250 µg, respectively, to intact mice and to animals previously treated with the drug for 3 days. The cytokine concentrations normalized after 3 h and increased again after 24 h, though did not reach the levels recorded 1 h after the drug injection. These data indicated that the therapeutic and preventive effects of Kagocel, together with its previously demonstrated stimulation of α- and ß-interferon production during several days, could be due to the capacity of this drug to increase the bone marrow ECF-MSC, serum cytokine concentrations, and induce the expression of proinflammatory cytokine genes in the bone marrow stromal cells 1 h after its injection.
Assuntos
Proliferação de Células/efeitos dos fármacos , Citocinas/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Gossipol/análogos & derivados , Células-Tronco Mesenquimais/efeitos dos fármacos , Animais , Antivirais/farmacologia , Corantes Azur , Técnicas de Cultura de Células , Citocinas/sangue , Citocinas/genética , Relação Dose-Resposta a Droga , Amarelo de Eosina-(YS) , Regulação da Expressão Gênica/imunologia , Gossipol/administração & dosagem , Gossipol/farmacologia , Técnicas Histológicas , Injeções Intraperitoneais , Masculino , Células-Tronco Mesenquimais/metabolismo , Camundongos , Camundongos Endogâmicos CBA , Poli I-C/administração & dosagem , Poli I-C/farmacologia , Fatores de TempoRESUMO
The concept of occult infection caused by hepatitis B virus (HBV) is determined as the presence of HBV DNA in blood sera or liver with the absence of detectable HBsAg. The actuality of this problem is associated with the fact, that occult hepatitis B (OHB) can be transmitted during hemotransfusions, cause reactivation of chronic hepatitis B in immune compromised individuals, facilitate development of liver cirrhosis and hepatocellular carcinoma. Several different hypotheses of OHB immunopathogenesis have been proposed, including a low number of copies of HBV DNA, altered immune response of the macroorganism, genetic variability of the S gene, integration of viral DNA into host genome, infection of mononuclear cells of peripheral blood, presence of immune complexes that hide HBsAg, and interference by other viruses such as HCV and HIV. Molecular mechanisms of HBV virus in HBsAg-negative individuals are not fully understood, however, viral mutations seem a very significant factor. Approaches of OHB prophylaxis including use of a polyvalent vaccine, that allows vaccination against wild and mutant HBV viruses, are examined.
Assuntos
Carcinoma Hepatocelular/prevenção & controle , DNA Viral/sangue , Vacinas contra Hepatite B/biossíntese , Hepatite B Crônica/prevenção & controle , Cirrose Hepática/prevenção & controle , Neoplasias Hepáticas/prevenção & controle , Complexo Antígeno-Anticorpo/sangue , Complexo Antígeno-Anticorpo/química , Carcinoma Hepatocelular/etiologia , Carcinoma Hepatocelular/imunologia , Carcinoma Hepatocelular/patologia , Variações do Número de Cópias de DNA , DNA Viral/imunologia , Antígenos de Superfície da Hepatite B/imunologia , Vacinas contra Hepatite B/administração & dosagem , Vacinas contra Hepatite B/imunologia , Vírus da Hepatite B/genética , Vírus da Hepatite B/imunologia , Hepatite B Crônica/complicações , Hepatite B Crônica/imunologia , Hepatite B Crônica/patologia , Humanos , Evasão da Resposta Imune , Fígado/imunologia , Fígado/virologia , Cirrose Hepática/etiologia , Cirrose Hepática/imunologia , Cirrose Hepática/patologia , Neoplasias Hepáticas/etiologia , Neoplasias Hepáticas/imunologia , Neoplasias Hepáticas/patologia , Mutação , VacinaçãoRESUMO
AIM: Study of macrophage migration inhibiting factor (MIF) effect after intracerebral administration on the course of experimental infection induced in mice by tick borne encephalitis virus (TEV), and study of sodium polyprenyl phosphate (PPP) and/or antibodies against MIF on the course of this infection against the background of MIF administration. MATERIALS AND METHODS: Phosprenil preparation was used as a source of PPP. PPP was administered intracerebrally. MIF--human recombinant (R&D, USA), mice--Balb/c line. RESULTS: In the sera of mice infected with TEV, MIF production stimulation was detected at days 8 through 10 after the infection--against the background of clinical signs presentation of tick borne encephalitis (TE). Administration of PPP to infected mice, on the contrary, resulted in MIF production suppression at the specified period. After administration of 20 ng of MIF to mice, lethality increased by 40% and average life span decreased by 2.3 days. Thus, MIF at high doses caused an increase of infection course severity, induced by TEV in mice, and administration of 60 microg of PPP resulted in the protection from infection in 100% of cases. Intracerebral administrationto mice of antibodies against MIF resulted in a decrease of lethality indicator up to 26% as compared with control and an increase of averagelife span by 5.5 days. During simultaneous administration into the brain of infected mice of MIF, PPP and antibodies against MIF, prevention of MIF-induced increase of TE course severity was registered. CONCLUSION: The data obtained allow to conclude that MIF may serve as an indicator of TE course severity, and possible prognostic indicator of meningo-encephalitic form development in humans.
Assuntos
Vírus da Encefalite Transmitidos por Carrapatos , Encefalite Transmitida por Carrapatos/imunologia , Fatores Inibidores da Migração de Macrófagos/imunologia , Fosfatos de Poli-Isoprenil/imunologia , Animais , Anticorpos/imunologia , Modelos Animais de Doenças , Feminino , Humanos , Fatores Inibidores da Migração de Macrófagos/administração & dosagem , Camundongos , Fosfatos de Poli-Isoprenil/administração & dosagemRESUMO
Plasmid pUC19-recAoc carrying a mutant allele of the recA gene, which plays the key role in the control of the SOS repair system and homologous recombinational repair, causes a 1.5-fold increase in radiation resistance of Escherichia coli DeltarecA cells, as compared to the wild-type recA+ cells. The protective effect of this plasmid is drastically reduced in mutant lexA3 recADelta21 deficient in the LexA protein and in induction of the SOS regulon. Plasmid pUC19-recAoc effectively suppresses UV sensitivity of the DeltarecA mutant. Mutation recAo20 allows constitutive high-level synthesis of the RecA protein. This mutation impairs the SOS box in the operator site of the recA gene and enhances heterology of the dimer LexA binding site. These data confirm that high level of the RecA protein synthesis per se is not sufficient for the expression of gamma-inducible functions and that the derepression of lexA-dependent genes, other than recA gene, is necessary for the complete induction of the SOS repair system.
Assuntos
Escherichia coli/metabolismo , Raios gama , Mutação , Regiões Operadoras Genéticas , Tolerância a Radiação/genética , Recombinases Rec A/metabolismo , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Escherichia coli/genética , Tolerância a Radiação/efeitos da radiação , Recombinases Rec A/genética , Resposta SOS em Genética/fisiologia , Resposta SOS em Genética/efeitos da radiação , Serina Endopeptidases/genética , Serina Endopeptidases/metabolismoRESUMO
I.I Mechnikov was the first who characterized phagocytosis as cellular defense mechanism. Infiltration of infectious process focus with phagocytes and subsequent activation of these cells is a fundamental defense reaction of the organism. However inflammation may be destructively dangerous if inflammatory response prolongates and/or generalization of the process leading to death of the host develops. The main trigger mechanisms in the pathogenesis of systemic inflammatory response and sepsis are release of bacterial endo- and exotoxins as well as hyperproduction of proinflammatory cytokines. Macrophage migration inhibitory factor (MIF) has exceptional multifunctionality and significant potential for activation of inflammatory system by various mechanisms acting as proinflammatory cytokine, hormone-contaregulator of immunosuppressive effect of corticosteroids and regulator of glucose metabolism. Data about the role of MIF as a crucially dangerous factor in pathogenesis of systemic inflammatory response obtained on experimental models of sepsis as well as about the efficacy of anti-MIF therapy were discussed, specific molecular mechanisms were analyzed. Prognostic value of high blood concentration of MIF during septic complications in clinic situations was assessed. In general, existing data on key role of MIF in sepsis pathogenesis show that MIF is one of the most promising targets for development of new strategies of immunotherapy for this life-threatening pathology.
Assuntos
Fatores Inibidores da Migração de Macrófagos/imunologia , Fagocitose , Sepse/imunologia , Síndrome de Resposta Inflamatória Sistêmica/imunologia , Animais , Citocinas/imunologia , Modelos Animais de Doenças , Humanos , Macrófagos/imunologia , CamundongosRESUMO
Comparative study of widely distributed on Russian market commercial test-systems for HBsAg detection by enzyme immunoassay was performed. Panel of serum samples containing mutant forms of HBsAg was developed for the study. It showed that only 2 out of 7 studied test-systems are able to detect mutant forms of HBsAg with the same sensitivity as "wild-type" forms of HBsAg. Test-systems based only on monoclonal antibodies did not detect HBsAg with G145R substitution in concentration 5 ng/ml. The study confirms the relevance of problem of HBsAg-mutants detection for hepatitis B immunodiagnostics.
Assuntos
Antígenos de Superfície da Hepatite B/sangue , Hepatite B/diagnóstico , Técnicas Imunoenzimáticas , Kit de Reagentes para Diagnóstico , Hepatite B/imunologia , Antígenos de Superfície da Hepatite B/genética , Humanos , Mutação , Sensibilidade e EspecificidadeRESUMO
The content of stromal precursor cells in the bone marrow of mice decreased 2-5.7 times 24 h after injection of macrophage migration inhibition factor in doses of 0.1-50 ng/kg, this reduction depending on the dose of inhibition factor. The content of precursor cells in the bone marrow of mice increased 2-fold 24 h after injection of S. typhimurium bacterial mass. One day after injection of S. typhimurium bacterial mass, the count of precursor cells in mouse spleen was 7-fold higher than 24 h after injection of macrophage migration inhibition factor. The efficiency of cloning of mouse bone marrow stromal precursor cells in vitro was suppressed 1.7-2.8 times in the presence of macrophage migration inhibition factor in doses of 0.1 to 50 ng/ml culture medium. The effect of cloning inhibition was preserved, if macrophage migration inhibition factor was added to the culture medium after 2 days of bone marrow cell culturing. In general, macrophage migration inhibition factor inhibits stromal precursor cells in vivo and in vitro. The data also indicate that macrophage migration inhibition factor is not responsible for rapid and sharp increase in the count of stromal precursor cells after immunization of animals.
Assuntos
Células da Medula Óssea/citologia , Células da Medula Óssea/efeitos dos fármacos , Fatores Inibidores da Migração de Macrófagos/farmacologia , Salmonella typhimurium/imunologia , Células Estromais/citologia , Células Estromais/efeitos dos fármacos , Animais , Antígenos de Bactérias/imunologia , Antígenos de Bactérias/farmacologia , Células Cultivadas , Cobaias , Camundongos , Camundongos Endogâmicos CBA , Baço/citologia , Baço/efeitos dos fármacosRESUMO
Algorithm of serologic screening for HBsAg-mutants in hepatitis B virus (HBV) carriers with high level of HBsAg was developed which is based on the detection of defects of interactions of serum HBsAg with monoclonal anti-HBs realizing as a decrease of ELISA sensitivity in 10 times or more during serial 10-fold dilutions. During 1st stage commercial test-systems based on monoclonal antibodies was used to select serum samples with discrepancy of test results. During 2nd stage HBsAg contained in selected sera was analyzed by the panel of monoclonal and polyclonal anti-HBs conjugates using decrease in ELISA sensitivity as a criterion. Serum samples from 2510 chronic carriers of HBV with high level of HBsAg were studied. 19 samples with discrepant results were found. Subsequent characterization of HBsAg with panel of 11 monoclonal and 1 polyclonal conjugates allowed to distinguish groups of sera with specific serologic "portraits". Atypical features of HBsAg were confirmed by genotyping 9 of 19 samples. Analysis of primary nucleotide sequence revealed serologically meaningful mutations in S-gene of HBV in all 9 isolates: 3 of them contained substitution mutation G145R, 5--S143L, and one--T143M. Distribution of mutations in HBsAg corresponded with specific serologic "portraits". Prevalence of HBsAg mutations in HBV carriers with high level of HBsAg was assessed for the first time: prevalence of G145R, S143L/T143M mutations, and all serologically atypical variants was 0.12%, 0.24%, and 0.76% respectively. Developed algorithm was proposed for epidemiologic monitoring of HBsAg-mutants of HBVand control of diagnostic test-systems.
Assuntos
Algoritmos , Monitoramento Ambiental/métodos , Antígenos de Superfície da Hepatite B/genética , Vírus da Hepatite B/imunologia , Hepatite B/sangue , Hepatite B/virologia , Anticorpos Monoclonais/imunologia , Anticorpos Antivirais/imunologia , Especificidade de Anticorpos , Portador Sadio , Ensaio de Imunoadsorção Enzimática/métodos , Monitoramento Epidemiológico , Hepatite B/diagnóstico , Hepatite B/prevenção & controle , Antígenos de Superfície da Hepatite B/sangue , Hepatite B Crônica/imunologia , Humanos , Programas de Rastreamento/métodos , Mutação Puntual , Prevalência , Federação Russa/epidemiologia , Sensibilidade e EspecificidadeRESUMO
It was shown, what in presence of oxygen in broad interval time of treatment in E. coli cells was induced line proteins by cysteamine which are proteins SOS--repair system and heat--shock system. There are quantitative defined induction level RecA, GroEL and DnaK proteins which are members this systems. It was allowed to propose what radioprotective action of cysteamine in higher degree is defined by its characteristics as induction agent for stress systems of cells.
Assuntos
Chaperonina 60/metabolismo , Cisteamina/farmacologia , Proteínas de Escherichia coli , Escherichia coli/metabolismo , Proteínas de Choque Térmico HSP70/metabolismo , Protetores contra Radiação/farmacologia , Recombinases Rec A/metabolismo , Proteínas de Bactérias/metabolismo , Escherichia coli/efeitos dos fármacos , Chaperonas Moleculares/metabolismoRESUMO
By RIA dot-blot method two main cell system, system SOS-repair and heat shock system, was showed possibility to receive as well qualitative as quantitative results influence of different induced agents. Was showed quantitative differences in initial levels enzymes of RecA and CroEL in different strains of E. coli, as well of principle possibility to using received antibody, which has high specific to this enzymes, for investigation reactions this systems in the other bacterial species, such as Bac. subtilis.
Assuntos
Bacillus subtilis/metabolismo , Chaperonina 60/metabolismo , Escherichia coli/metabolismo , Recombinases Rec A/metabolismo , Antibióticos Antineoplásicos/farmacologia , Anticorpos Antibacterianos , Bacillus subtilis/efeitos da radiação , Chaperonina 60/imunologia , Escherichia coli/efeitos da radiação , Transtornos de Estresse por Calor , Mitomicinas/farmacologia , Radioimunoensaio/métodos , Recombinases Rec A/imunologia , Resposta SOS em GenéticaRESUMO
Mice F1 (CBA x C57Bl) life span after transplantation of standard number of leukemia EL-4 cells at different clock hours was evaluated. At the same time, as injection was done, rectal temperature of mouse was measured. Both parameters showed circadian trend. Mice life span was in negative correlation with rectal temperature. So it is possible to consider temperature rhythm as marker rhythm of natural antitumor resistance.
Assuntos
Temperatura Corporal , Leucemia Experimental/imunologia , Animais , Imunidade Inata/imunologia , Leucemia Experimental/fisiopatologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Transplante de Neoplasias , RetoRESUMO
Many children with chronic cicatricial stenosis of the larynx and trachea showed a high activity of the factor stimulating macrophage migration in vitro (MSF). The high MSF level is typical of patients with large scars in tissues rich in cellular elements. The MSF predominance was to a certain extent correlated with abnormal responses to surgical intervention. This was indicated by poor results of surgical treatment if the MSF was low before and immediately after it. With normal MSF the treatment was effective in at least 50% of cases. The therapeutic effectiveness was correlated with MSF variations at an early postoperative stage.
Assuntos
Proteínas Sanguíneas/análise , Laringoestenose/sangue , Fatores Inibidores da Migração de Macrófagos/fisiologia , Macrófagos/imunologia , Estenose Traqueal/sangue , Adolescente , Proteínas Sanguíneas/metabolismo , Proteínas Sanguíneas/ultraestrutura , Inibição de Migração Celular , Criança , Pré-Escolar , Doença Crônica , Feminino , Humanos , Laringoestenose/cirurgia , Masculino , Estenose Traqueal/cirurgiaRESUMO
Simple highly sensitive screening variant of viral immunoassay for detection of nanogram quantity of antigen is proposed. The antigen linked with antibodies adsorbed on polystyrene 96-well plates was revealed by conjugate of Fab' fragments of antibodies with phage phi X174. The concentration of the antigen could be detected qualitatively and quantitatively (from 0.3 ng/ml to 1000 ng/ml).
Assuntos
Antígenos Virais/análise , Bacteriófago phi X 174/imunologia , Programas de Rastreamento/métodos , Animais , Humanos , Imunoensaio/instrumentação , Imunoensaio/métodos , Fragmentos Fab das Imunoglobulinas/imunologia , Coelhos , Ratos , Ensaio de Placa ViralRESUMO
A technique of macrophage-activating factors (MAF) detection by the in vitro determination of macrophage (Mph) antitumour cytolytic activity by 3H-thymidine residue in the pre-labelled neoplastic target cells (TC) is suggested. Peptone-induced Mph were cultivated for 20-22 hours in the presence of crude supernatants from concanavalin-A-stimulated spleen cells or from the secondary mixed lymphocyte culture. 3H-thymidine-labelled cells of mastocytoma P815 were then added to the washed Mph. The lysis was measured in 48 hours according to the isotope remainder in the non-acid-soluble fraction. The optimal conditions for MAF detection have been selected. Parallel MAF testing with this particular method and with a standard technique using labelled 51Cr TC made it possible to conclude that the method suggested is more sensitive because it permits a combined cultivation of Mph and TC for a relatively long time period.
Assuntos
Citotoxicidade Imunológica , Linfocinas/análise , Ativação de Macrófagos , Neoplasias Experimentais/imunologia , Animais , Linhagem Celular , Concanavalina A/farmacologia , Fatores Ativadores de Macrófagos , Métodos , Camundongos , Camundongos Endogâmicos , Timidina/análiseRESUMO
A study was made of the mouse life span in relation to the time of tumor cell injection on an hourly basis, while the carcinogenic effect was studied in relation to the time of urethan injection. Changes in both the values were shown to vary with ultradian rhythms. It was found that natural killer cell activity against tumor cells, migration index of normal spleen cells in the presence of tumor cells and the activity of carcinogen-metabolising enzyme system of intact animals also exhibited ultradian oscillations. It is assumed that oscillations of natural resistance against transplantable or chemically-induced tumor may be due to the changes of these parameters.
Assuntos
Ciclos de Atividade , Ritmo Circadiano , Neoplasias Experimentais/imunologia , Animais , Movimento Celular , Sistema Enzimático do Citocromo P-450/análise , Feminino , Imunidade Inata , Células Matadoras Naturais/imunologia , Masculino , Camundongos , Camundongos Endogâmicos A , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Transplante de Neoplasias , Neoplasias Experimentais/etiologia , Neoplasias Experimentais/mortalidade , Baço/imunologia , Fatores de Tempo , UretanaRESUMO
F1(MSU X WAG) rats were immunized with anti B6 BALB/c specific suppressor T cells (SSTC), purified by absorption/elution technique, with the following fusion of splenocytes to NS-I myeloma cell line. Hybrids were screened for their ability to affect SSTC, cytotoxic T lymphocytes (CTL) and producers of macrophage migration inhibition factor (MIF-producers) all triggered by in vivo priming with allogeneic cells. Two hybridoma cell lines--C1 and C4 inactivated SSTC by approximately 50%, leaving CTL and MIF-producers intact. C4 were also active in vivo, if injected as ascitic fluid from nu/nu mice, though to a lesser extent than in vitro.